Successful treatment of headache related to intravenous immunoglobulin with antimigraine medications

Headache

Volumn 38, Issue 4, 1998, Pages 317-321

  Finkel, Alan G ^a,b   Howard Jr , James F ^a   Mann, J Douglas ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Dihydroergotamine mesylate; Headache; Immunology; Intravenous immunoglobulin; Migraine; Sumatriptan

Indexed keywords

ANTIMIGRAINE AGENT; DIHYDROERGOTAMINE MESILATE; IMMUNOGLOBULIN; SEROTONIN AGONIST; SUMATRIPTAN;

ADULT; ARTICLE; CASE REPORT; DRUG EFFECT; FEMALE; HEADACHE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT OUTCOME;

EID: 0031946851     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1998.3804317.x     Document Type: Article

References (26)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors. JAMA. 1992;267:64-69.
2. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):19-28.
3. The Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med. 1991;325:316-321.
4. Saxena PR, Ferrari MD. From serotonin receptor classification to the antimigraine drug sumatriptan. Cephalalgia. 1992;12:187-196.
5. Lauritzen M. Pathophysiology of the migraine aura. The spreading depression theory. Brain. 1994;117:199-210.
6. 1-like receptor. Cephalalgia. 1992;12:202-205.
7. Goadsby PJ, Zagami AS, Lambert GA. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache. 1991;31:365-371.
8. IB/ID receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine. Cephalalgia. 1991;11:165-168.
9. Sekul EA, Cupler EJ, Dalakas MC. Aseptic meningitis associated with high-dose intravenous immunoglobulin therapy: frequency and risk factors. Ann Intern Med. 1994;121:259-262.
10. Berkman SA, Lee ML, Gale RP. Clinical uses of intravenous irnmunoglobulins. Ann Int Med. 1990;112:278-292.
11. Arsura EL, Bick A, Brunner NG, Namba T, Grob D. High-dose intravenous immunoglobulin in the management of myasthenia gravis. Arch Intern Med. 1986;146:1365-1368.
12. Soueidan SA, Dalakas MC. Treatment of autoimmune neuromuscular diseases with high-dose intravenous immune globulin. Pediatr Res. 1993;33(suppl):S95-S100.
13. Sekul EA, Soueidan SA, Cupler EJ, Dalakas MC. Intravenous immunoglobulin-associated meningitis: frequency and risk factors in treatment of patients with neuromuscular disease. Neurology. 1993;43:A203. Abstract.
14. Constantinescu CS, Chang AP, McCluskey LF. Recurrent migraine and intravenous immune globulin therapy. N Engl J Med. 1993;329:583-584.
15. Jones J, Sklar D, Dougherty J, White W. Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA. 1989;261:1174-1176.
16. Lederman HM, Roifman CM, Lavi S, Gelfand EW. Corticosteroids for prevention of adverse reactions to intravenous immune serum globulin infusions in hypogammaglobulinemic patients. Am J Med. 1986;81:443-446.
17. Damasio H, Beck D. Migraine thrombocytopenia, and serotonin metabolism. Lancet. 1978;1:240-242.
18. Lord GD, Duckworth JW. Immunoglobulin and complement studies in migraine. Headache. 1977;17:163-168.
19. Rubin LS, Boyer J. A correlative study of immunoglobulin isotype expression in common migraine. Headache. 1986;26:137-141.
20. Martelletti P, Alteri E, Pesce A, Rinaldi-Garaci C, Giacovazzo M. In vitro interactions of serotonin (5-HT) with mononuclear cells from migraine patients: alterations related to the phase of the attack. J Neuroimmunol. 1988;18:17-24.
21. Covelli V, Maffione AB, Munno I, Jirillo E. Alterations of nonspecific immunity in patients with common migraine. J Clin Lab Anal. 1990;4:9-15.
22. Hering R, Gardiner I, Catarci T, Whitmarsh T, Steiner T, de Belleroche J. Cellular adaptation in migraineurs with chronic daily headache. Cephalalgia. 1993;13:261-266.
23. Lord GD, Duckworth JW, Charlesworth JA. Complement activation in migraine. Lancet. 1977;1:781-782.
24. Giacovazzo M, Di Mario U, Martelletti P. Immunological phenomena in cluster headache: a controversy. Headache. 1987;27:224-225.
25. Visintini D, Trabattoni G, Manzoni GC, Lechi A, Bortone L, Behan PO. Immunological studies in cluster headache and migraine. Headache. 1986;26:398-402.
26. Smith RS. The cytokine theory of headache. Med Hypotheses. 1992;39:168-174.